Cortnee Roman
Family · Salt Lake City, UTNPI 1356585210
Payments from drug & device makers
$373,560in general payments, 2019–2025
Across 1,216 payments — averaging $307.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$155K
- TG Therapeutics, Inc.$77K
- Amgen$45K
- E.r. Squibb & Sons, L.L.C.$29K
- AstraZeneca$23K
- EMD Serono, Inc.$10K
- plus $35K from 33 others
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 275 | $155,083 |
| TG Therapeutics, Inc. | 148 | $77,211 |
| Amgen(2 entities) | 113 | $45,142 |
| E.r. Squibb & Sons, L.L.C. | 56 | $28,548 |
| AstraZeneca | 48 | $23,000 |
| EMD Serono, Inc. | 127 | $9,874 |
| UCB, Inc. | 23 | $8,626 |
| Bristol Myers Squibb | 90 | $8,606 |
| Genentech USA, Inc. | 30 | $6,495 |
| Novartis | 119 | $6,052 |
| AbbVie(2 entities) | 66 | $1,146 |
| Banner Life Sciences, LLC | 10 | $913 |
| Sanofi | 20 | $645 |
| Argenx US, Inc. | 12 | $303 |
| SK Life Science, Inc. | 13 | $293 |
| Axsome Therapeutics, Inc. | 9 | $174 |
| Janssen Scientific Affairs, LLC | 5 | $167 |
| Genentech, Inc. | 6 | $166 |
| Pfizer | 9 | $150 |
| Johnson & Johnson(2 entities) | 3 | $147 |
| Eisai Inc. | 4 | $101 |
| CSL Behring | 3 | $93 |
| Lilly USA, LLC | 5 | $90 |
| Abbott | 1 | $88 |
| ANI Pharmaceuticals, Inc. | 4 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Cycle Pharmaceuticals Inc | 2 | $44 |
| Mylan Specialty L.p. | 1 | $39 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Grifols USA, LLC | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $19 |
| Sandoz | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Neurelis, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$373,560 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Other family in Salt Lake City
- Katrina BawdenSalt Lake City$446K
- Jared ThorleySalt Lake City$368K
- Mary SteinbackSalt Lake City$189K
- Jennalyn MayeuxSalt Lake City$151K
- Kacie Doyle-DelgadoSalt Lake City$80K
- Melonie ThompsonSalt Lake City$45K
- Michelle LitchmanSalt Lake City$44K
- Keisa LynchSalt Lake City$39K
- Christina CardonSalt Lake City$36K
- Jessica ArbogastSalt Lake City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.